Clinical Research

Research for Better Cancer Treatments

Access to New Therapies

Cancer medicine is constantly evolving. New medications and treatment methods are continuously researched and tested to make therapies more effective and better tolerated.

At the Tumor Zentrum Aargau, our physicians have been participating in clinical trials and scientific research projects for many years. This enables us to provide our patients with access to new treatment options while offering care based on the latest scientific evidence.

Significance for our patients

New treatment options within clinical trials

Clinical trials investigate new medications, new combinations of existing therapies, or new treatment strategies. The goal is to further improve cancer treatments.

For patients, participation in a study can represent an additional treatment option in certain situations. At the same time, clinical trials contribute to the further development of knowledge regarding cancer treatments.

Whether participation in a study is possible or advisable is always assessed individually in consultation with the treating physicians.

Klinische Forschung Tumor Zentrum Aargau

Participation in clinical trials

Voluntary participation following detailed consultation

Participation in a clinical trial is always voluntary. Prior to potential participation, patients are informed in detail about the objectives, procedures, possible benefits, and risks.

Only after this briefing do patients decide, together with their treating physicians, whether participation is an option.

Should you choose to participate in a study, you will be closely supported by both your treating physician and our study team. We are always available to answer your questions.

Further information on ongoing studies can be found here:

Scientific Collaboration

Research in Networks

Clinical research at the Tumor Zentrum Aargau is part of close collaboration with national and international scientific organizations and study groups.

These include collaborations with:

  • Swiss Tumor Institute

  • European Organisation for Research and Treatment of Cancer (EORTC)

This network enables access to current scientific developments and supports treatment according to the latest medical standards.